Please login to the form below

Not currently logged in
Email:
Password:

Owen Mumford appoints general manager for SEMEA

Eric Del Cotto to oversee operations of medical device firm in Southern Europe, Middle East and Africa

Eric Del Cotto, Owen MumfordUK medical device firm Owen Mumford has appointed Eric Del Cotto as general manager for the Southern Europe, Middle East and Africa (SEMEA) region.

Del Cotto replaces Owen Mumford's general manager for France Philippe Meersch, who retires at the end of September, with the SEMEA position implemented as part of a restructure of the company's global operations.

The new role is based in France and involves the management of sales, marketing, customer service and business development teams to promote Owen Mumford's medical devices in the region.

Del Cotto has worked in the healthcare industry for 30 years, including most recently at KCI Medical in France, where he managed a global team of marketing and business development specialists.

He also has experience at Molnlycke Healthcarein Sweden and 3M Healthcare in France.

Jarl Severn, managing director, paid tribute to the departing Meersch, who had been with Owen Mumford for 22 years.

“We wish him well in his retirement and thank him for his invaluable contribution to the business,” said Servern.

He added: “I am looking forward to working with Eric and have every confidence we will see Owen Mumford's presence increase substantially across the SEMEA region under his expert leadership.”

20th September 2013

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics